navigation
Awards
AbbVie Swiss HIV cohort grant 2017
Prize awarded to
Catia Marzolini and Laurent Decosterd
‘Model-based simulation and clinical validation of drug-drug interactions in the SHCS‘
from left to right:
Ralph Torgler, PhD, Medical Manager HCV, AbbVie AG Switzerland,
Pascal Roulin, PhD, Medical Scientific Liaison, AbbVie AG Switzerland,
Dr. Catia Marzolini, PD, Forschungsgruppenleiterin Pharmakologische HIV-Forschung, Universitätsspital Basel, and,
Dr. Laurent Decosterd, Professeur associé, Faculté de biologie et médecine, Université de Lausanne
AbbVie Swiss HIV cohort grant 2016
Prize awarded to
Hans H. Hirsch and Francesca Compagno
‘Transmission of JC polyomavirus in HIV-infected patients’
from left to right:
Prof. Dr. Hans H. Hirsch, Leitender Arzt Universitätsspital Basel; Leiter Abteilung Infektionsdiagnostik, und
Leiter Forschungsgruppe “Transplantation & Clinical Virology”, Dept. Biomedizin, Universität Basel,
Francesca Compagno, Research Associate “Transplantation & Clinical Virology”, Dept. Biomedizin, Universität Basel,
Mr Ralph Torgler, Medical Manager HCV , AbbVie AG Switzerland, and
Mr Philippe Dähler, Sales Manager Specialty Care, AbbVie AG Switzerland.
AbbVie Swiss HIV cohort grant 2015
Prize awarded to
Philip Tarr
‘Population kinetic modelling of metabolic in HIV-infected individuals’
left to right: Dr. med Sandra Bloch, Medical Director, AbbVie AG Switzerland, PD Dr. med. Philip Tarr,
Leitender Arzt im Kantonsspital Baselland, and Dr. Felix Keller, Director Specialty Care, AbbVie AG Switzerland.
AbbVie Swiss HIV cohort grant 2014
Prize awarded to
George Shirreff, Tanja Stadler, Roger Kouyos, Huldrych F. Günthard and Sebastian Bonhoeffer
“How does HIV-1 drug resistance evolve at a population level?“
left to right: Dr. Felix Keller, Head of Specialty AbbVie AG Switzerland, Assistant Prof. Tanja Stadler,
ETH Zurich, and Dr. Med. LG Patricia Kellerhals, Medical Director AbbVie AG Switzerland.
AbbVie Swiss HIV cohort grant 2013
First prize awarded to
Matthias Cavassini, Samanta Simioni, Renaud Du Pasquier and al.
“Neurocognitive Assessment in the Metabolic and Aging Cohort.
The NAMACO study“
left to right: Dr. Patricia Kellerhals, Medical Director AbbVie AG Switzerland, Dr. Matthias Cavassini
and Mr Victor Schallehn, Business Unit Manager Virologie Abbvie AG Switzerland.
Second prize awarded to
Gilles Wandeler and al.
“Reason for late testing and delayed presentation
to HIV care in Switzerland”
left to right: Dr. Patricia Kellerhals, Medical Director AbbVie AG Switzerland, Dr. Gilles Wandeler
and Mr Victor Schallehn, Business Unit Manager Virologie Abbvie AG Switzerland.
AbbVie Swiss HIV cohort grant 2012
1st prize awarded to
Karoline Aebi-Popp et al.
Missed opportunities among HIV-infected women to control viral replication during pregnancy and to deliver spontaneously in countries with a vaginal delivery policy. The Swiss Mother & Child HIV Cohort Study and the European Collaborative Study.
left to right: Mr Victor Schallehn representing Abbott, Mrs Karoline Aebi-Popp, Mr Patrick Francioli outgoing president of the SHCS
2nd prize awarded to
Huldrych Günthard et al.
Long-term trends and transmission of individual drug resistance mutations as defined by the IAS-USA mutation list in the Swiss HIV cohort Study and dependence on changing antiretroviral treatment regimens. The Swiss HIV Cohort Study
left to right: Mr Victor Schallehn representing Abbott, Mr Huldrych Günthard, Mr Patrick Francioli outgoing president of the SHCS
Abbott Swiss HIV cohort grant 2006-2011
| 2011 | 1st prizes ex aequo | Cardiovascular disease outcome in HIV infected patients: A retrospective cohort analysis Alexandra Calmy et al. |
| Viral genotype as study phenotype in human genome-wide association analysis Jacques Fellay et al. | ||
| 2010 | 1st prize | Measuring the heritability of set-point viral load in HIV-1 infections Samuel Alizon et al. |
| 2nd prize | Prevalence of HEV infection among SHCS participants with unexplained consecutive ALT elevations Alain Kenfak et al. | |
| 2009 | 1st prize | Immunogenetic andgenomic analysis of severe HIV disease Amalio Telenti |
| 2nd prize | Ultra-deep sequencing of HIV: a pilot study evaluating the benefit for predicting therapy outcome Osvaldo Zagordi et al. | |
| 2008 | 1st prizes ex aequo | Prevalence of proximal renal tubulopathy in tenofovir-treated patients within the SHCS Christoph Fux et al. |
| Host Genetics in Hepatitis C Virus Infection Andri Rauch et al. | ||
| 2007 | 1st prize | Impact of HIV and antiretroviral therapy on hepatitis C virus evolution and HCV-specific cellular immunity Andri Rauch et al. |
| 2nd prize | Cognitive disorders in HIV-infected patients in the HAART era in Geneva and Lausanne: a feasibility and therapeutic studies Renaud Arthur Du Pasquier et al. | |
| 2006 | 1st prize | Prospective evaluation of non-invasive fibrosis assessment and breath test for quantification of liver function in patients with HIV/HCV-coinfection Patrick Schmid et al. |
| 2nd prize | Antiretroviral therapy of HIV-infected intravenous drug users and persons in a drug addiction treatment program: The Swiss HIV Cohort Study Milo Huber et al. | |